arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Personalis, Inc.

PSNL
$14.14 ▲ +1.12 (+8.64%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
10 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
18
Health
Poor
Bearish
auto_awesome

Analytical Summary

Personalis, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.3B
Dividend Yield
Revenue Growth -17.7%
Op. Margin -126.4%
ROIC -33.7%
FCF / Share $-0.89
Trailing P/E
Price / Book 5.6x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

10-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$69.65M
↓ -17.7%
Net Income Profit after all expenses
$-81.27M
— 0.0%
Operating Margin Operating profit as % of sales
-126.4%
↓ -56.7% 1th
FCF / Share Free cash flow per share
$-0.89
↓ -12.8%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
2
Returns
23
Financial Health
7
Cash Quality
64

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 35 quarters